IP Library Granted Patent US 8,115,011
Granted Patent B2
US 8,115,011 · App. 12/113,261 · Granted Feb 14, 2012

Diacylglycerol acyltransferase inhibitors

Assignee: Madrigal Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,115,011
App. No.
12/113,261
Granted
Feb 14, 2012
Kind
B2
Abstract

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.

Claims (292)

1. A compound of formula (I):

wherein:

R 1 is phenyl unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 2 is N;

R 3 is N;

R 4 is C;

R 5 is CH;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

R 7 is NR a , O or absent, wherein R a is H or lower alkyl;

R 8 is CR b R c , NR b , O or absent, wherein each of R b and R c , independently, is H or lower alkyl; wherein both R 7 and R 8 are not absent;

R 9 is

-lower alkyl,

-alkoxy,

-hydroxy,

-amine,

-lower alkyl amine,

-haloloweralkyl,

-lower alkoxy,

-lower alkenyloxy,

-cycloloweralkyl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents selected from lower alkyl, hydroxy, halogen, —SO 2 -loweralkyl, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-6-membered aryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

—(CH 2 ) n C(O)OH,

—CH 2 C(lower alkyl) 2 C(O)OH,

—CH 2 (cycloalkyl)C(O)OH,

-(cycloalkyl)C(O)OH,

—CH 2 C(CH 3 ) 3 ,

—(CH 2 ) n -cycloalkyl,

-cycloalkenyl,

-bicycloalkenyl-C(O)OH,

—(CH 2 ) n —O-alkyl,

—O—C(═C)-lower alkyl,

—O—(CH 2 ) n -phenyl,

—NSO 2 -loweralkyl,

—NSO 2 -cycloalkyl,

—NSO 2 -aryl,

—N-lower alkyl,

—N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH,

—N-heterocycloalkyl,

—N-aryl,

—N—(CH 2 ) n -aryl,

—N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,

—N—CH(lower alkyl)C(O)OH,

—N-(cycloalkyl)C(O)OH,

—N—CH(lower alkyl)C(O)O-lower alkyl, or

-phenyl-C(O)OH,

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

n is 1, 2 or 3,

or pharmaceutically acceptable salts thereof.

2. The compound according to claim 1 , wherein:

R 1 is phenyl unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 2 is N;

R 3 is N;

R 4 is C;

R 5 is CH;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

R 7 is NR a , O or absent, wherein R a is H or lower alkyl;

R 8 is CR b R c , NR b , O or absent, wherein each of R b and R c , independently, is H or lower alkyl; wherein both R 7 and R 8 are not absent;

R 9 is

-lower alkyl,

-alkoxy,

-hydroxy,

-amine,

-lower alkyl amine,

-haloloweralkyl,

-lower alkoxy,

-lower alkenyloxy,

-cycloloweralkyl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents selected from lower alkyl, hydroxy, halogen, —SO 2 -loweralkyl, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-6-membered aryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

—(CH 2 ) n C(O)OH,

—CH 2 C(lower alkyl) 2 C(O)OH,

—CH 2 (cycloalkyl)C(O)OH,

-(cycloalkyl)C(O)OH,

—CH 2 C(CH 3 ) 3 ,

—(CH 2 ) n -cycloalkyl,

-cycloalkenyl,

-bicycloalkenyl-C(O)OH,

—O—C(═C)-lower alkyl,

—O—(CH 2 ) n -phenyl,

—NSO 2 -loweralkyl,

—NSO 2 -cycloalkyl,

—NSO 2 -aryl,

—N-lower alkyl,

—N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH,

—N-heterocycloalkyl,

—N-aryl,

—N—(CH 2 ) n -aryl,

—N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,

—N—CH(lower alkyl)C(O)OH,

—N-(cycloalkyl)C(O)OH,

—N—CH(lower alkyl)C(O)O-lower alkyl, or

-phenyl-C(O)OH,

X is 6-membered aryl, unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

n is 1, 2 or 3.

3. The compound according to claim 1 , wherein:

R 1 is phenyl unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 2 is N;

R 3 is N;

R 4 is C;

R 5 is CH;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

R 7 is NR a , O or absent, wherein R a is H or lower alkyl;

R 8 is CR b R c , NR b , O or absent, wherein each of R b and R c , independently, is H or lower alkyl; wherein both R 7 and R 8 are not absent;

R 9 is

-lower alkyl,

-alkoxy,

-hydroxy,

-amine,

-lower alkyl amine,

-haloloweralkyl,

-lower alkoxy,

-lower alkenyloxy,

-cycloloweralkyl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents selected from lower alkyl, hydroxy, halogen, —SO 2 -loweralkyl, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-6-membered aryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

—(CH 2 ) n C(O)OH,

—CH 2 C(lower alkyl) 2 C(O)OH,

—CH 2 (cycloalkyl)C(O)OH,

-(cycloalkyl)C(O)OH,

—CH 2 C(CH 3 ) 3 ,

—(CH 2 ) n -cycloalkyl,

-cycloalkenyl,

-bicycloalkenyl-C(O)OH,

—(CH 2 ) n —O-alkyl,

—O—C(═C)-lower alkyl,

—O—(CH 2 ) n -phenyl,

—NSO 2 -loweralkyl,

—NSO 2 -cycloalkyl,

—NSO 2 -aryl,

—N-lower alkyl,

—N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH,

—N-heterocycloalkyl,

—N-aryl,

—N—(CH 2 ) n -aryl,

—N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,

—N—CH(lower alkyl)C(O)OH,

—N-(cycloalkyl)C(O)OH,

—N—CH(lower alkyl)C(O)O-lower alkyl, or

-phenyl-C(O)OH,

X is 5- or 6-membered heteroaryl, unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

n is 1, 2 or 3.

4. The compound according to claim 1 , wherein:

R 1 is phenyl, unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 2 is N;

R 3 is N;

R 4 is C;

R 5 is CH;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

R 7 is NR a , O or absent, wherein R a is H or lower alkyl;

R 8 is CR b R c , NR b , O or absent, wherein each of R b and R c , independently, is H or lower alkyl; wherein both R 7 and R 8 are not absent;

R 9 is

-lower alkyl,

-alkoxy,

-hydroxy,

-amine,

-lower alkyl amine,

-haloloweralkyl,

-lower alkoxy,

-lower alkenyloxy,

-cycloloweralkyl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents selected from lower alkyl, hydroxy, halogen, —SO 2 -loweralkyl, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-6-membered aryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

—(CH 2 ) n C(O)OH,

—CH 2 C(lower alkyl) 2 C(O)OH,

—CH 2 (cycloalkyl)C(O)OH,

-(cycloalkyl)C(O)OH,

—CH 2 C(CH 3 ) 3 ,

—(CH 2 ) n -cycloalkyl,

-cycloalkenyl,

-bicycloalkenyl-C(O)OH,

—(CH 2 ) n —O-alkyl,

—O—C(═C)-lower alkyl,

—O—(CH 2 ) n -phenyl,

—NSO 2 -loweralkyl,

—NSO 2 -cycloalkyl,

—NSO 2 -aryl,

—N-lower alkyl,

—N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH,

—N-heterocycloalkyl,

—N-aryl,

—N—(CH 2 ) n -aryl,

—N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,

—N—CH(lower alkyl)C(O)OH,

—N-(cycloalkyl)C(O)OH,

—N—CH(lower alkyl)C(O)O-lower alkyl, or

-phenyl-C(O)OH,

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is phenyl, unsubstituted or substituted with lower alkyl, halogen or cyano; and

n is 1, 2 or 3.

5. The compound according to claim 1 , wherein:

R 1 is phenyl unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 2 is N;

R 3 is N;

R 4 is C;

R 5 is CH;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

R 7 is NR a , O or absent, wherein R a is H or lower alkyl;

R 8 is CR b R c , NR b , O or absent, wherein each of R b and R c , independently, is H or lower alkyl; wherein both R 7 and R 8 are not absent;

R 9 is

-lower alkyl,

-alkoxy,

-hydroxy,

-amine,

-lower alkyl amine,

-haloloweralkyl,

-lower alkoxy,

-lower alkenyloxy,

-cycloloweralkyl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents selected from lower alkyl, hydroxy, halogen, —SO 2 -loweralkyl, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-6-membered aryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

-5- or 6-membered heteroaryl, unsubstituted or substituted with one to four substituents selected from lower alkyl, hydroxy, halogen, —C(O)OH, C(O)O-lower alkyl and —C(O)O-lower alkyl-phenyl,

—(CH 2 ) n C(O)OH,

—CH 2 C(lower alkyl) 2 C(O)OH,

—CH 2 (cycloalkyl)C(O)OH,

-(cycloalkyl)C(O)OH,

—CH 2 C(CH 3 ) 3 ,

—(CH 2 ) n -cycloalkyl,

-cycloalkenyl,

-bicycloalkenyl-C(O)OH,

—(CH 2 ) n —O-alkyl,

—O—C(═C)-lower alkyl,

—O—(CH 2 ) n -phenyl,

—NSO 2 -loweralkyl,

—NSO 2 -cycloalkyl,

—NSO 2 -aryl,

—N-lower alkyl,

—N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH,

—N-heterocycloalkyl,

—N-aryl,

—N—(CH 2 ) n -aryl,

—N-heteroaryl, said heteroaryl being unsubstituted or substituted with alkyl,

—N—CH(lower alkyl)C(O)OH,

—N-(cycloalkyl)C(O)OH,

—N—CH(lower alkyl)C(O)O-lower alkyl, or

-phenyl-C(O)OH,

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is cycloloweralkyl or 5- or 6-membered heterocycloalkyl, said cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

n is 1, 2 or 3.

6. The compound according to claim 1 , wherein:

R 1 is phenyl, unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ; and

X is 6-membered aryl, unsubstituted or substituted with lower alkyl, halogen or cyano.

7. The compound according to claim 1 , wherein:

R 1 is phenyl, unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ; and

X is 5- or 6-membered heteroaryl, unsubstituted or substituted with lower alkyl, halogen or cyano.

8. The compound according to claim 1 , wherein:

R 1 is phenyl, unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ; and

Y is phenyl, unsubstituted or substituted with lower alkyl, halogen or cyano.

9. The compound according to claim 1 , wherein:

R 1 is phenyl, unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ; and

Y is cycloloweralkyl or 5- or 6-membered heterocycloalkyl, said cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano.

10. The compound according to claim 1 , wherein:

X is 6-membered aryl, unsubstituted or substituted with lower alkyl, halogen or cyano; and

Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano.

11. The compound according to claim 1 , wherein:

X is 5- or 6-membered heteroaryl, unsubstituted or substituted with lower alkyl, halogen or cyano; and

Y is phenyl, heteroaryl, cycloloweralkyl, or 5- or 6-membered heterocycloalkyl, said phenyl, cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano.

12. The compound according to claim 1 , wherein:

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

Y is phenyl, unsubstituted or substituted with lower alkyl, halogen or cyano.

13. The compound according to claim 1 , wherein:

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano; and

Y is cycloloweralkyl or 5- or 6-membered heterocycloalkyl, said cycloloweralkyl or heterocycloalkyl being unsubstituted or substituted with lower alkyl, halogen or cyano.

14. The compound according to claim 1 , wherein X is phenyl, pyridine or pyrimidine.

15. The compound according to claim 1 , wherein R 6 is halogen, trifluoromethyl, trifluoroethyl, methyl, ethyl, propyl, methoxymethyl or methoxyethyl.

16. The compound according to claim 1 , wherein R 7 is NR a , wherein R a is H or lower alkyl.

17. The compound according to claim 1 , wherein R 8 is NR b , wherein R b is H or lower alkyl.

18. The compound according to claim 1 , wherein R 9 is lower alkyl, alkoxy, hydroxy, lower alkyl amine; cycloloweralkyl, unsubstituted or substituted with one to four substituents from loweralkyl, hydroxy, halogen, —C(O)OH, —C(O)O-lower alkyl or —C(O)O-lower alkyl-phenyl; 5- or 6-membered heterocycloalkyl, unsubstituted or substituted, with one to four substituents from lower alkyl, hydroxy, halogen, —SO2-loweralkyl, —C(O)OH, —C(O)O-lower alkyl or —C(O)O-lower alkyl-phenyl; (CH 2 ) n C(O)OH; CH 2 C(lower alkyl) 2 C(O)OH; CH 2 (cycloalkyl)C(O)OH; (cycloalkyl)C(O)OH; NSO 2 -loweralkyl; N-lower alkyl; N-cycloalkyl, said cycloalkyl being unsubstituted or substituted with —C(O)OH; N—CH(lower alkyl)C(O)OH; or —N-(cycloalkyl)C(O)OH.

19. The compound according to claim 1 , wherein Y is phenyl, pyridine, piperazine, piperidine, pyrrolidine or cyclopentane.

20. A compound selected from the group consisting of:

(S)-3-{5-[(1-Pyridin-2-yl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester,

(S)-3-{4-[(1-Phenyl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-phenylamino}-pyrrolidine-1-carboxylic acid ethyl ester,

(S)-3-{5-[(1-Phenyl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester,

(S)-3-{5-[(4-Methyl-2-pyridin-2-yl-thiazole-5-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester, and

(S)-3-5-[(4-Methyl-2-pyridin-2-yl-thiazole-5-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid tert-butyl ester.

21. A compound of the formula

wherein:

R 1 is a phenyl ring unsubstituted or substituted with halogen, lower alkyl, alkoxy or O—CF 3 ;

R 6 is halogen, lower alkyl, haloloweralkyl or alkoxy;

X is 6-membered aryl or 5- or 6-membered heteroaryl, said aryl or heteroaryl being unsubstituted or substituted with lower alkyl, halogen or cyano;

Y is a phenyl ring, a heteroaryl ring, cycloloweralkyl ring, or 5- or 6-membered heterocycloalkyl ring, said phenyl, cycloloweralkyl or heterocycloalkyl rings being unsubstituted or substituted with lower alkyl, halogen or cyano; and

R 9 is halogen, lower alkyl, haloloweralkyl or alkoxy;

or pharmaceutically acceptable salts thereof.

22. The compound of claim 21 wherein Y is a 5 or 6 heterocycloalkyl ring having one of its ring carbon atoms replaced by a nitrogen atom.

23. A compound selected from 3-{5-[(1-phenyl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1- carboxylic acid ethyl ester, 3-{4-[(1-phenyl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-phenylamino}-pyrrolidine-1-carboxylic acid ethyl ester, and their pharmaceutically acceptable salts.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVISOUSLY RECORDED ON REEL 027216 FRAME 0440.ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST Recorded Jun 12, 2012
From: VIA, LLC
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 028390/0021 →
COLLATERAL ASSIGNMENT OF PATENTS Recorded Nov 16, 2011
From: MADRIGAL PHARMACEUTICALS, INC.
To: BAY CITY CAPITAL FUND IV, L.P.
Reel/Frame 027241/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2011
From: VIA PHARMACEUTICALS, INC.
To: VIA, LLC
Reel/Frame 027216/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2011
From: VIA, LLC
To: MADRIGAL PHARMACEUTICALS, INC.
Reel/Frame 027216/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: HOFFMANN-LA ROCHE INC.
To: VIA PHARMACEUTICALS, INC.
Reel/Frame 022552/0847 →
Continuity (3)
Provisional Application 60931273 · May 22, 2007
Provisional Application 61037341 · Mar 18, 2008
Related Publication 20090170864A1 · Jul 2, 2009